Geneva Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$3.46M Sell
43,014
-7,202
-14% -$569K 0.06% 148
2017
Q1
$3.94M Sell
50,216
-4,564
-8% -$364K 0.07% 140
2016
Q4
$4.32M Sell
54,780
-202,698
-79% -$16.4M 0.08% 126
2016
Q3
$22.9M Sell
257,478
-112,719
-30% -$10.6M 0.43% 71
2016
Q2
$35.4M Sell
370,197
-5,500
-1% -$548K 0.7% 52
2016
Q1
$39M Buy
375,697
+68,968
+22% +$6.71M 0.78% 50
2015
Q4
$30M Buy
306,729
+16,661
+6% +$1.63M 0.58% 58
2015
Q3
$28M Buy
290,068
+15,389
+6% +$1.62M 0.56% 58
2015
Q2
$28.8M Buy
274,679
+2,871
+1% +$293K 0.51% 64
2015
Q1
$28.1M Sell
271,808
-1,612
-0.6% -$163K 0.51% 65
2014
Q4
$26.3M Buy
273,420
+207,961
+318% +$18.3M 0.49% 68
2014
Q3
$5.21M Buy
65,459
+2,991
+5% +$236K 0.1% 123
2014
Q2
$4.71M Buy
62,468
+40,554
+185% +$3.06M 0.09% 132
2014
Q1
$1.64M Buy
21,914
+5,112
+30% +$361K 0.03% 225
2013
Q4
$1.2M Buy
16,802
+151
+0.9% +$9.7K 0.02% 234
2013
Q3
$945K Sell
16,651
-1,562
-9% -$93.1K 0.02% 256
2013
Q2
$1.04M Buy
+18,213
New +$1.06M 0.02% 212

Other funds holding CVS

Geneva Advisors's CVS Position: Q2 2017 in Review

Geneva Advisors reduced its CVS Health (CVS) stake by 14% in Q2 2017, selling an estimated $569K and leaving 43,014 shares worth $3.46M. The position accounts for 0.06% of the portfolio, ranked #148.

Geneva Advisors first reported a position in CVS in Q2 2013 and has held it in 17 quarters since. The position peaked at $39M in Q1 2016. 1,552 funds tracked by Wall St. Rank hold CVS as of Q2 2017.

  • Geneva Advisors held 43,014 shares of CVS Health worth $3.46M as of Q2 2017.
  • Geneva Advisors sold 7,202 CVS Health shares in Q2 2017, an estimated $569K.
  • CVS Health made up 0.06% of Geneva Advisors's portfolio in Q2 2017, its #148 holding.
  • Geneva Advisors first reported a position in CVS Health in Q2 2013 and has held it in 17 quarters since.
  • Geneva Advisors's CVS Health position peaked at $39M in Q1 2016.
  • 1,552 funds tracked by Wall St. Rank held CVS Health as of Q2 2017.

Based on Geneva Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.